1. Biomarkers for pediatric cancer detection: latest advances and future perspectives
   Teresa Stachowicz-Stencel et al, 2020, Biomarkers in Medicine CrossRef
2. Galectin-3: an immune checkpoint target for musculoskeletal tumor patients
   Kosei Nakajima et al, 2021, Cancer and Metastasis Reviews CrossRef
3. Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma
   Guillermo Herrador-Cañete et al, 2022, Molecular Therapy - Oncolytics CrossRef
4. Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management
   Kosei Nakajima et al, 2016, Cancer and Metastasis Reviews CrossRef
5. Chalcone Derivatives 4′-Amino-1-Naphthyl-Chalcone (D14) and 4′-Amino-4-Methyl-1-Naphthyl-Chalcone (D15) Suppress Migration and Invasion of Osteosarcoma Cells Mediated by p53 Regulating EMT-Related Genes
   Viviane Seba et al, 2018, International Journal of Molecular Sciences CrossRef
6. Prognostic value of serum aquaporin-1, aquaporin-3 and galectin-3 for young patients with colon cancer
   Yanyan Hong et al, 2020, Annals of Clinical Biochemistry: International Journal of Laboratory Medicine CrossRef
7. Establishment of a prognostic risk model for osteosarcoma and mechanistic investigation
   Hongyuan Jiang et al, 2024, Frontiers in Pharmacology CrossRef
8. Identification of Prognostic and Predictive Osteosarcoma Biomarkers
   Radoslav Zamborsky et al, 2019, Medical Sciences CrossRef
9. Long non-coding RNA Rpph1 promotes inflammation and proliferation of mesangial cells in diabetic nephropathy via an interaction with Gal-3
   Panyang Zhang et al, 2019, Cell Death & Disease CrossRef